UnitedHealth Group (NYSE:UNH) Suspends 2025 Outlook As CEO Hemsley Rejoins Team
UnitedHealth Group recently experienced significant developments, including the appointment of Stephen J. Hemsley as CEO after Andrew Witty's resignation, and the suspension of its 2025 earnings outlook due to accelerating care activities and higher-than-expected medical costs. These significant internal shifts may have influenced the company's substantial 21% share price decline over the last week. In contrast, the overall market saw a 3.9% rise, highlighting the unique challenges faced by UNH amid market optimism driven by the expected 14% earnings growth in the broader market over the forthcoming years.
We've identified 1 risk for UnitedHealth Group that you should be aware of.
Find companies with promising cash flow potential yet trading below their fair value.
The recent leadership changes at UnitedHealth Group, alongside the indefinite suspension of its 2025 earnings outlook due to escalating care activities, could further challenge its revenue and earnings growth. This uncertainty might influence investor sentiment, especially against the backdrop of the company's short-term 21% share price decline. Over the longer-term, however, the total shareholder return was 15.93% over the past five years, highlighting the company's resilience in delivering value to investors over time despite recent setbacks.
The company's past year's performance has seen some underperformance compared to the broader US market, which had an 11.6% return, underscoring the pressure from unexpected changes in Medicare dynamics and higher medical costs. These factors could continue to affect UnitedHealth's ability to achieve projected earnings, with existing revenue forecasts suggesting a 9.4% annual growth over the next three years. The share price's recent drop brings it to approximately US$394.51, which is substantially below the consensus analyst price target of US$539.95, indicating potential upside should the company manage to align its growing operational challenges with the expectations built into these valuations.
Upon reviewing our latest valuation report, UnitedHealth Group's share price might be too pessimistic.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NYSE:UNH.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Saratoga Investment (NYSE:SAR) shareholders have earned a 19% CAGR over the last five years
If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share price move up more than the market average. But Saratoga Investment Corp. (NYSE:SAR) has fallen short of that second goal, with a share price rise of 45% over five years, which is below the market return. But if you include dividends then the return is market-beating. Over the last twelve months the stock price has risen a very respectable 5.1%. Let's take a look at the underlying fundamentals over the longer term, and see if they've been consistent with shareholders returns. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. During five years of share price growth, Saratoga Investment actually saw its EPS drop 21% per year. This means it's unlikely the market is judging the company based on earnings growth. Since the change in EPS doesn't seem to correlate with the change in share price, it's worth taking a look at other metrics. In fact, the dividend has increased over time, which is a positive. It could be that the company is reaching maturity and dividend investors are buying for the yield. The revenue growth of about 24% per year might also encourage buyers. You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values). We know that Saratoga Investment has improved its bottom line lately, but what does the future have in store? So we recommend checking out this free report showing consensus forecasts It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. As it happens, Saratoga Investment's TSR for the last 5 years was 144%, which exceeds the share price return mentioned earlier. And there's no prize for guessing that the dividend payments largely explain the divergence! It's nice to see that Saratoga Investment shareholders have received a total shareholder return of 21% over the last year. And that does include the dividend. Since the one-year TSR is better than the five-year TSR (the latter coming in at 19% per year), it would seem that the stock's performance has improved in recent times. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 3 warning signs for Saratoga Investment (1 is potentially serious!) that you should be aware of before investing here. But note: Saratoga Investment may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
41 minutes ago
- Yahoo
With A 9.6% Return On Equity, Is Ball Corporation (NYSE:BALL) A Quality Stock?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). To keep the lesson grounded in practicality, we'll use ROE to better understand Ball Corporation (NYSE:BALL). Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. Put another way, it reveals the company's success at turning shareholder investments into profits. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. The formula for return on equity is: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Ball is: 9.6% = US$532m ÷ US$5.6b (Based on the trailing twelve months to March 2025). The 'return' refers to a company's earnings over the last year. Another way to think of that is that for every $1 worth of equity, the company was able to earn $0.10 in profit. See our latest analysis for Ball Arguably the easiest way to assess company's ROE is to compare it with the average in its industry. However, this method is only useful as a rough check, because companies do differ quite a bit within the same industry classification. If you look at the image below, you can see Ball has a lower ROE than the average (14%) in the Packaging industry classification. That's not what we like to see. Although, we think that a lower ROE could still mean that a company has the opportunity to better its returns with the use of leverage, provided its existing debt levels are low. When a company has low ROE but high debt levels, we would be cautious as the risk involved is too high. To know the 2 risks we have identified for Ball visit our risks dashboard for free. Virtually all companies need money to invest in the business, to grow profits. That cash can come from retained earnings, issuing new shares (equity), or debt. In the first two cases, the ROE will capture this use of capital to grow. In the latter case, the use of debt will improve the returns, but will not change the equity. In this manner the use of debt will boost ROE, even though the core economics of the business stay the same. Ball clearly uses a high amount of debt to boost returns, as it has a debt to equity ratio of 1.21. Its ROE is quite low, even with the use of significant debt; that's not a good result, in our opinion. Debt does bring extra risk, so it's only really worthwhile when a company generates some decent returns from it. Return on equity is a useful indicator of the ability of a business to generate profits and return them to shareholders. A company that can achieve a high return on equity without debt could be considered a high quality business. If two companies have around the same level of debt to equity, and one has a higher ROE, I'd generally prefer the one with higher ROE. But ROE is just one piece of a bigger puzzle, since high quality businesses often trade on high multiples of earnings. The rate at which profits are likely to grow, relative to the expectations of profit growth reflected in the current price, must be considered, too. So you might want to take a peek at this data-rich interactive graph of forecasts for the company. But note: Ball may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Everest Group Insiders Placed Bullish Bets Worth US$1.34m
Over the last year, a good number of insiders have significantly increased their holdings in Everest Group, Ltd. (NYSE:EG). This is encouraging because it indicates that insiders are more optimistic about the company's prospects. While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. The Independent Director William Galtney made the biggest insider purchase in the last 12 months. That single transaction was for US$1.0m worth of shares at a price of US$349 each. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$335). While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We always take careful note of the price insiders pay when purchasing shares. Generally speaking, it catches our eye when insiders have purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. Happily, we note that in the last year insiders paid US$1.3m for 3.87k shares. But insiders sold 2.80k shares worth US$1m. In the last twelve months there was more buying than selling by Everest Group insiders. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below! See our latest analysis for Everest Group Everest Group is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying. There was substantially more insider selling, than buying, of Everest Group shares over the last three months. In that time, Independent Director Geraldine Losquadro dumped US$541k worth of shares. Meanwhile CEO, President & Director James Williamson bought US$338k worth. Because the selling vastly outweighs the buying, we'd say this is a somewhat bearish sign. For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Everest Group insiders own 1.4% of the company, currently worth about US$200m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders. Unfortunately, there has been more insider selling of Everest Group stock, than buying, in the last three months. In contrast, they appear keener if you look at the last twelve months. We are also comforted by the high levels of insider ownership. So we're not too bothered by recent selling. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Everest Group. You'd be interested to know, that we found 1 warning sign for Everest Group and we suggest you have a look. If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
